Modeling ophthalmic drug delivery by soaked contact lenses

Industrial and Engineering Chemistry Research

Volumn 45, Issue 10, 2006, Pages 3718-3734

  Li, Chi Chung ^a   Chauhan, Anuj ^a  

^a University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLINK; DRUG DELIVERY; OPHTHALMIC DRUG; TEAR FILMS;

ABSORPTION; COMPUTER SIMULATION; CONTACT LENSES; DIFFUSION; DISPERSIONS; DRUG PRODUCTS; MASS TRANSFER; MATHEMATICAL MODELS; PERTURBATION TECHNIQUES;

PHARMACODYNAMICS;

ABSORPTION; COMPUTER SIMULATION; CONTACT LENSES; DIFFUSION; DISPERSIONS; DRUG PRODUCTS; MASS TRANSFER; MATHEMATICAL MODELS; PERTURBATION TECHNIQUES; PHARMACODYNAMICS;

EID: 33744521916     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie0507934     Document Type: Article

References (50)

1. Bourlals, C. L.; Acar, L.; Zia, H.; Sado P. A.; Needham, T.; Leverge, R. Ophthalmic drug delivery systems. Prog. Retinal Eye Res. 1998, 17 (1), 33-58.
2. Urtti, A.; Salminen, L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv. Ophthalmol. 1993, 37 (6), 435-456.
3. TIMPOTIC prescribing information, supplied by Merck: Whitehouse Station, NJ.
4. Segal, M. Patches Pumps and timed release. FDA Consum. 1991, October.
5. Saettone, M. F.; Chetoni, P.; Torraca, M. T.; Burgalassi, S.; Giannaccini, B. Evaluation of mucoadhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int. J. Pharm. 1989, 51, 203-212.
6. Saettone, M. F.; Teneggi, A.; Savigni, P.; Tellini, N. Vehicle effects on ophthalmic bioavailability. The influence of different polymers. J. Pharm. Pharmacol. 1982, 34, 464-466.
7. Davies, N. M.; Farr, S. J.; Hadgraft, J.; Kellaway, I. W. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions. Pharm. Res. 1982, 9 (9), 1137-1144.
8. Greaves, J. L.; Olejnik, O.; Wilson, C. G. Polymers and the precorneal tear film. STP Pharma Sci. 1992, 2(1), 13-33.
9. Kyyronen, K.; Urtti, A. Improved ocular: Systemic absorption ratio of Timolol by viscous vehicle and phenylephrine. Invest. Ophthalmol. Visual Sci. 1990, 31 (9), 1827-1833.
10. Hiementz, P. C.; Rajagopalan R. Principles of colloid and surface chemistry, 3rd ed.; Marcel Dekker: New York, 1997.
11. Fitzerald, P.; Hadgraft, J.; Kreuter, J.; Wilcon, C. G. A gamma scintigraphic evaluation of microparticulate ophthalmic delivery systems: Liposomes and nanoparticles. Int. J. Pharm. 1987, 40, 81-84.
12. Lee, V. H. L. Applications of liposomes in ocular drug delivery. Liposomes in Ophthalmology and Dermatology; Pleyer, U., Schmidt, K., Thiel, H. J., Eds; 1993; pp 53-59.
13. Marchal-Heussler, L.; Sirbat, D.; Hoffman, M.; Maincent, P. Poly(ε-caprolactone) nanocapsules in carteolol ophthalmic drug delivery. Pharm. Res. 1993, 10 (3), 386-390.
14. Calvo, P.; Vila-Lato, J.; Alonso, M. J. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsiuons as ocular drug carriers. J. Pharm. Sci. 1996, 85 (5), 530-536.
15. Calvo, P.; Sanchez, A.; Martinez, J.; Lopez, M. I.; Calonge, M.; Pastor, J. C.; Alonso, M. J. Polyster nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharm. Res. 1996, 13 (2), 311-315.
16. Li, V. H. K.; Wood, R. W.; Kreuter, J.; Harmia, T.; Robinson, J. R. Ocular drug delivery of progesterone using nanoparticles. J. Microencapsulation 1986, 3 (3), 213-218.
17. Zimmer, A. K.; Kreuter, J.; Robinson, J. R. Studies on transport pathways of PBCA nanoparticles in ocular tissues. J. Microencapsulation 1991, 8 (4), 497-504.
18. Lee, V. H. L. Review: New directions in the optimization of ocular drug delivery. J. Ocul. Pharmacol. 1990, 6 (2), 157-164.
19. Sawusch, M. R.; O'Brien, T. P.; Dick, J. D.; Ottsch, J. D. Use of collagen corneal shields in the treatment of bacterial kearatitis. Am. J. Ophthalmol. 1988, 106, 279-281.
20. Vasantha, R.; Sehgal, P. K.; Panduranga Rao, K. Collagen ophthalmic inserts for pilocarpine drug delivery systems. Int. J. Pharm. 1988, 47, 95-102.
21. Gurtler, F.; Gurny, R. Patent literature review of ophthalmic inserts. Drug. Dev. Ind. Pharm. 1995, 21 (1), 1-18.
22. Creech, J. L.; Chauhan, A.; Radke, C. J. Dispersive mixing in the posterior tear film under a soft contact lens. Ind. Eng. Chem. Res. 2001, 40, 3015-3026.
23. McNamara, N. A.; Polse, K. A.; Brand, R. D.; Graham, A. D.; Chan, J. S.; McKenney, C. D. Tear mixing under a soft contact lens: Effects of lens diameter. Am. J. Ophthalmol. 1999, 127 (6), 659-665.
24. Peppas, N. A. Hydrogels in medicine and pharmacy, Vol. 1 & 2; CRC Press Inc.: Boca Raton, FL, 1986.
25. Gulsen, D.; Chauhan, A. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle. Int. J. Pharm. 2005, 292 (1-2), 95-117.
26. Gulsen, D.; Chauhan, A. Ophthalmic Drug Delivery through Contact Lenses. Invest. Ophthalmol. Visual Sci. 2004, 45 (7), 2342-2347.
27. Hehl, E. M.; Beck, R.; Luthard, K.; Guthoff, R.; et al. Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur. J. Clin. Pharmacol, 1999, 55 (4), 317-323.
28. Nakada, K.; Sugiyama, A. Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced. U.S. Patent 6,027,745, May 29, 1998.
29. Hillman, J. S. Management of acute glaucoma with Pilocarpinesoaked hydrophilic lens. Brit. J. Ophthalmol. 1974, 58, 674-679.
30. Ramer, R.; Gasset, A. Ocular Penetration of Pilocarpine. Ann. Ophthalmol. 1974, 6, 1325-1327.
31. Montague, R.; Wakins, R. Pilocarpine dispensation for the soft hydrophilic contact lens. Brit. J. Ophthalmol. 1975, 59, 455-458.
32. Hillman, J.; Masters, J.; Broad, A. Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma. Trans. Ophthalmol. Soc. U.K. 1975, 79-84.
33. Giambattista, B.; Virno, M.; Pecori-Giraldi, J.; Pellegrino, N.; Motolese, E. Possibility of Isoproterenol Therapy with Soft Contact Lenses: Ocular Hypotension Without Systemic Effects. Ann. Ophthalmol. 1976, 8, 819-829.
34. Marmion, V. J.; Yardakul, S. Pilocarpine administration by contact lens Trans. Ophthalmol. Soc. U.K. 1977, 97, 162-163.
35. Schultz, C. L.; Mint, J. M. Drug delivery system for antiglaucomatous medication. U.S. Patent 6,410,045.
36. Rosenwald, P. L. Ocular device. U.S. Patent 4,484,922.
37. Schultz, C. L.; Nunez, I. M.; Silor, D. L.; Neil, M. L. Contact lens containing a leachable absorbed material. U.S. Patent 5,723,131.
38. Garcia, D. M.; Escobar, J. L.; Noa, Y.; Bada, N.; Hernaez, E.; Katime, I. Timolol maleate release from pH-sensible poly(2-hydroxyethyl methacrylate-co-methacrylic acid) hydrogels. Eur. Polym. J. 2004, 40 (8), 1683-1690.
39. Hiratani, H.; Alvarez-Lorenzo, C. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials 2004, 25 (6), 1105-1113.
40. Alverez-Lorenzo, C.; Hiratani, H.; Gomez-Amoza, J. L.; Martinez-Pacheco, R.; Souto, C.; Concheiro, A. Soft contact lenses capable of sustained delivery of timolol. J. Pharm. Sci. 2002, 91 (10), 2182-2192.
41. Karlgard, C.; Wong, N. S.; Jones, L.; Moresoli, C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int. J. Pharm. 2003, 257, 141-151.
42. Chauhan, A.; Radke, C. J. Modeling the vertical motion of a soft contact lens. Curr. Eye Res. 2001, 22 (2), 102-108.
43. Chauhan, A.; Radke, C. J. Settling and deformation of a soft contact lens. Invest. Ophthalmol. Visual Sci. 2001,42 (4), S589;
44. J. Colloid Interface Sci. 2002, 245, 187-197.
45. Chauhan, A.; Radke, C. J. The Role of Fenestrations and Channels on the Transverse Motion of a Soft Contact Lens. Optometry Vision Sci. 2001, 78 (10), 732-743.
46. Tiffany, J. M. The Viscosity of Human Tears. Int. Ophthalmol. 1991, 15, 371.
47. Fantini, S.; Clohessy, J.; Gorgy, K.; Fusalba, F.; Johans, C.; Kontturi, K.; Cunnane, V. J. Influence of the presence of a gel in the water phase on the electrochemical transfer of ionic forms of b-blockers across a large water-1,2-dichloroethane interface. Eur. J. Pharm. Sci. 2003, 18, 251-257.
48. Hiratani, H.; Alvarez-Lorenzo, C. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. J. Controlled Release 2002, 83, 223-230.
49. Edwards, A.; Prausnitz, M. R. Predicted permeability of the cornea to topical drugs. Pharm. Res. 2001, 18 (11), 1497-1508.
50. Prausnitz, M. R.; Noonan, J. S. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J. Pharm. Sci. 1998, 87 (12), 1479-1488.